Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass

PHASE3CompletedINTERVENTIONAL
Enrollment

882

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Coronary Artery Bypass GraftingMitral Valve SurgeryLow Cardiac Output Syndrome
Interventions
DRUG

Levosimendan

DRUG

Placebo

matching placebo

Trial Locations (60)

Unknown

University of Alabama at Burlington Hospital, Burlington

Huntsville Hospital, Huntsville

Mercy General Hospital, Sacramento

University of California San Diego Medical Center, San Diego

Stanford University School of Medicine, Stanford

Hartford Hospital, Hartford

Yale-New Haven Hospital, New Haven

Boca Raton Community Hospital, Boca Raton

Shands Hospital at the University of Florida, Gainesville

Tampa General Hospital, Tampa

Redmond Regional Medical Center, Rome

Northwestern University Hospital, Evanston

Lutheran Hospital of Indiana, Fort Wayne

Franciscan St. Francis Health, Indianapolis

Iowa Heart Center/ Mercy Medical Center, West Des Moines

University of Louisville Hospital, Louisville

Maine Medical Center, Portland

Brigham and Women's Hospital, Boston

Tufts Medical Center, Boston

St. Joseph's Mercy Hospital, Ann Arbor

Oakwood Hospital and Medical Center, Dearborn

Spectrum Health, Grand Rapids

St. Luke's Hospital, Kansas City

Barnes Jewish Hospital, St Louis

Nebraska Heart Institute, Lincoln

Nebraska Medical Center, Omaha

Morristown Medical Center, Morristown

St. Peter's Hospital, Albany

Columbia University Medical Center, New York

Lenox Hill Hospital, New York

Mount Sinai Medical Center, New York

Saint Francis Hospital/The Heart Center, Roslyn

Mission Hospital, Asheville

Moses H. Cone Memorial Hospital, Greensboro

Duke University Hospital, Raleigh

The Christ's Hospital; Lindner Clinical Trial Center, Cincinnati

Case Medical Center, Cleveland

Cleveland Clinic, Cleveland

Ohio State University Hospital, Columbus

ProMedica Toledo Hospital, Toledo

Oklahoma Heart Hospital, Oklahoma City

Lehigh Valley Hospital, Allentown

St. Thomas Heart, Nashville

Vanderbilt University Medical Center, Nashville

Baylor Hospital, Dallas

The Heart Hospital Baylor Plano, Plano

University of Virginia Health System, Charlottesville

Franciscan Health System Res. Center, Tacoma

Aurora Saint Luke's Medical Center, Milwaukee

University of Alberta Hospital, Edmonton

Royal Jubilee Hospital (Vancouver Island Health Authority), Victoria

Victoria Heart Institute Foundation, Victoria

St. Boniface Hospital, Winnepeg

Hamilton Health Sciences, Hamilton

London Health Sciences Center, University Hospital, London

Southlake Regional Health Center, Newmarket

St. Michael's Hospital, Toronto

McGill University Health Centre-Royal Victoria Hospital, Montreal

Montreal Heart Institute, Montreal

Institute universitaire de cardiologie et pneumologie de Quebec, Québec

All Listed Sponsors
lead

Tenax Therapeutics, Inc.

INDUSTRY

NCT02025621 - Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter